To the Editor In an Original Investigation published in a recent issue of JAMA Internal Medicine, Watkins and colleagues¹ conducted an important trial of collaborative care for primary care patients with probable alcohol and/or opioid use disorders (AUDs and/or OUDs). Considering a previous negative trial² of primary care management for patients with AUDs and/or other drug use disorders,² the SUMMIT trial¹ is exciting because it suggests that 6 sessions of behavioral therapy, offered in primary care, could increase abstinence from alcohol and/or opioid use in patients with probable AUDs and/or OUDs. These results are very promising for guiding future clinical care and research. However, there are 2 areas in which the trial report¹ lacks specificity for interpreting and applying results.

致编辑在最近一期的《JAMA内科杂志》上发表的原始调查中，Watkins及其同事¹对患有可能的酒精和/或阿片类药物使用障碍（AUD和/或OUD）的初级保健患者进行了一项重要的协作治疗试验。考虑先前的负试验²初级保健管理的患者AUD中和/或其它药物使用障碍，²的SUMMIT试验¹之所以令人兴奋是因为它表明，在可能的AUD和/或OUD的患者中，在初级保健中提供6个阶段的行为疗法可能会增加戒酒和/或使用阿片类药物的禁欲。这些结果对于指导未来的临床护理和研究非常有希望。但是，在2个方面，试验报告¹缺乏解释和应用结果的特异性。